Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India · Delayed Price · Currency is INR 1,206.90
-35.90 (-2.89%)
At close: Jan 8, 2026
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,811 employees as of March 31, 2025. The number of employees increased by 763 or 2.82% compared to the previous year.
Employees
27,811
Change (1Y)
763
Growth (1Y)
2.82%
Revenue / Employee
12.30M INR
Profits / Employee
2.11M INR
Market Cap
1.01T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,811 | 763 | 2.82% |
| Mar 31, 2024 | 27,048 | 1,185 | 4.58% |
| Mar 31, 2023 | 25,863 | 1,068 | 4.31% |
| Mar 31, 2022 | 24,795 | 2,056 | 9.04% |
| Mar 31, 2021 | 22,739 | 1,089 | 5.03% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
Dr. Reddy's Laboratories News
- 5 days ago - Pharma generics: Semaglutide patent expiry to open Rs 50bn opportunity; Indian players eye FY27 boost - The Times of India
- 6 days ago - Dr Reddy’s shares fall nearly 2% today as JPMorgan flags USFDA setback, cuts target to Rs 1,170 - Business Upturn
- 6 days ago - Dr. Reddy’s Laboratories in focus today as JPMorgan flags regulatory setback - Business Upturn
- 7 days ago - Nifty 50 top losers today, January 1: ITC, Dr. Reddy’s, Bajaj Finance, Tata Consumer Products, ONGC, Cipla and more - Business Upturn
- 8 days ago - Dr Reddy, Cipla, Sun Pharma and other stocks in focus today as Govt bans high-dose Nimesulide formulations - Business Upturn
- 15 days ago - Nifty 50 top losers today, December 24: IndiGo, Dr. Reddy’s, Wipro, Adani Enterprises, HDFC Life, Tata Motors PV and more - Business Upturn
- 15 days ago - Dr Reddy’s Laboratories shares in focus as company’s semaglutide not approved in Canada – Know More - Business Upturn
- 15 days ago - Dr Reddy’s semaglutide not approved in Canada as Health Canada flags regulatory gaps: Report - Business Upturn